Bank Hapoalim BM Purchases Shares of 89,200 Teladoc Health, Inc. $TDOC

Bank Hapoalim BM purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC) during the second quarter, Holdings Channel reports. The institutional investor purchased 89,200 shares of the health services provider’s stock, valued at approximately $777,000.

Other hedge funds also recently bought and sold shares of the company. Golden State Wealth Management LLC raised its position in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 1,690 shares in the last quarter. National Bank of Canada FI raised its position in Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,581 shares in the last quarter. SVB Wealth LLC acquired a new stake in Teladoc Health in the 1st quarter valued at about $37,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Teladoc Health in the 1st quarter valued at about $50,000. Finally, Ameritas Advisory Services LLC acquired a new stake in Teladoc Health in the 2nd quarter valued at about $78,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analyst Ratings Changes

TDOC has been the topic of a number of analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a research report on Saturday, September 27th. Mizuho began coverage on Teladoc Health in a research report on Friday, July 25th. They set a “neutral” rating and a $10.00 target price on the stock. Finally, Evercore ISI raised their target price on Teladoc Health from $7.00 to $8.00 and gave the stock an “in-line” rating in a research report on Wednesday, July 9th. Six equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $9.80.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $9.01 on Friday. The stock’s 50-day simple moving average is $7.66 and its 200-day simple moving average is $7.60. The firm has a market capitalization of $1.59 billion, a PE ratio of -7.57 and a beta of 1.90. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.08. The firm had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. As a group, equities research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.